Comments
Novartis India today reported a net profit of Rs 59.81 crore for the third quarter ended December 31, 2015.
The company had posted a net loss of Rs 1.18 crore in the same period last fiscal, Novartis India said in a BSE filing.
Net sales during the period under review stood at Rs 183.38 crore, while in the same period last fiscal it was at Rs 213.02 crore.
During the quarter, pharmaceuticals business had a revenue of Rs 158.61 crore, while income from generics was at Rs 8.9 crore.
Novartis India said the results are not comparable with the corresponding period of the previous fiscal due to implications of global divestment of OTC business by its parent to GSK. In India, it had completed the transfer of the business on September 30, 2015.
Novartis India shares ended down by 7 per cent at Rs 671.25 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.